Veterinary Medicines

Calcitat 50, oplossing voor infusie voor runderen

Authorised
  • Calcium borogluconate
  • Magnesium chloride hexahydrate
  • Calcium hydroxide
  • Calcium gluconate
Download as PDF

Product identification

Medicine name:
Calcitat 50, oplossing voor infusie voor runderen
Active substance:
  • Calcium borogluconate
  • Magnesium chloride hexahydrate
  • Calcium hydroxide
  • Calcium gluconate
Target species:
  • Cattle
Route of administration:
  • Intravenous use
  • Intravenous use

Product details

Active substance and strength:
  • Calcium borogluconate
    429.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Magnesium chloride hexahydrate
    65.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Calcium hydroxide
    13.20
    milligram(s)
    /
    1.00
    millilitre(s)
  • Calcium gluconate
    31.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for infusion
Withdrawal period by route of administration:
  • Intravenous use
    • Cattle
      • Meat and offal
        no withdrawal period
  • Intravenous use
    • Cattle
      • Milk
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA12AX
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Available in:
  • Netherlands
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • aniMedica GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Pasteur Filiala Filipesti S.A.
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 3745
Date of authorisation status change:

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 17/12/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."